N-[2-(8-cyclohexylnaphthalen-1-yl)phenyl]-N-(4-cyclopropa[a]inden-3-ylphenyl)dibenzothiophen-4-amine
C50H37NS — CID 170300953
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(8-cyclohexylnaphthalen-1-yl)phenyl]-N-(4-cyclopropa[a]inden-3-ylphenyl)dibenzothiophen-4-amine
N-[2-(8-cyclohexylnaphthalen-1-yl)phenyl]-N-(4-cyclopropa[a]inden-3-ylphenyl)dibenzothiophen-4-amine (PubChem CID 170300953) has the molecular formula C50H37NS and a molecular weight of 683.92 g/mol. Its IUPAC name is N-[2-(8-cyclohexylnaphthalen-1-yl)phenyl]-N-(4-cyclopropa[a]inden-3-ylphenyl)dibenzothiophen-4-amine.
Molecular Properties
| Compound Name | N-[2-(8-cyclohexylnaphthalen-1-yl)phenyl]-N-(4-cyclopropa[a]inden-3-ylphenyl)dibenzothiophen-4-amine |
|---|---|
| PubChem CID | 170300953 |
| Molecular Formula | C50H37NS |
| Molecular Weight | 683.92 g/mol |
| Exact Mass | 683.26 |
| IUPAC Name | N-[2-(8-cyclohexylnaphthalen-1-yl)phenyl]-N-(4-cyclopropa[a]inden-3-ylphenyl)dibenzothiophen-4-amine |
| SMILES | c1ccc(N(c2ccc(-c3ccc4cc5cc-5c4c3)cc2)c2cccc3c2sc2ccccc23)c(-c2cccc3cccc(C4CCCCC4)c23)c1 |
| InChI | InChI=1S/C50H37NS/c1-2-11-33(12-3-1)39-17-8-13-34-14-9-18-42(49(34)39)40-15-4-6-20-46(40)51(47-21-10-19-43-41-16-5-7-22-48(41)52-50(43)47)38-27-25-32(26-28-38)35-23-24-36-29-37-31-45(37)44(36)30-35/h4-10,13-31,33H,1-3,11-12H2 |
| InChIKey | FKRXYFVTALCMJX-UHFFFAOYSA-N |
| XLogP | 15.19 |
| TPSA | 3.24 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 683.92 |
| LogP ≤ 5 | 15.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170300953 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.